m+Medelevator.RU
← Поиск публикаций
medRxiv : the preprint server for health sciences · 2025

Fecal Short-Chain Fatty Acids Vary by Sex and Amyloid Status.

СтатьяПрепринтНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Kuehn Jessamine F, Zhang Qijun, Heston Margo B, Kang Jea Woo, Harding Sandra J, Davenport-Sis Nancy J, Peter Darby C, Kerby Robert L, Vemuganti Vaibhav, Schiffmann Emma C, Tallon Michael M, Harpt Joseph, Hajra Arun, Wheeler J L, Shankar Sushma, Mickol Alissa, Zemberi Justus, Chow Hana, Zhang Eric, Clements Eleanor, Noughani Hanna, Forst Allison, Everitt Grace, Kollmorgen Gwendlyn, Quijano-Rubio Clara, Christian Bradley T, Carlsson Cynthia M, Johnson Sterling C, Asthana Sanjay, Zetterberg Henrik, Blennow Kaj, Ulland Tyler K, Rey Federico E, Bendlin Barbara B

Аннотация

INTRODUCTION: Short-chain fatty acids (SCFAs), produced by gut microbes, influence Alzheimer's disease (AD) pathology in animals. Less is known about SCFAs and AD in humans. We profiled feces of adults along the AD continuum to investigate gut microbiome and SCFA associations with AD pathology and cognition.

METHODS: We measured SCFAs and bacterial abundances in fecal samples from 287 participants in the Wisconsin Alzheimer's Disease Research Center and Wisconsin Registry for Alzheimer's Prevention. We performed regressions examining associations between SCFAs or gut microbes and AD pathology and cognition.

RESULTS: Fecal propionate, isovalerate, and propionate-producing bacteria are inversely associated with amyloid status. Mediation analysis found that propionate mediates sex-specific associations between SCFAs and CSF biomarkers. SCFA levels are associated with slower cognitive decline.

DISCUSSION: These results link SCFAs and propionate-producing bacteria with AD. This may inform efforts to leverage diet and specific bacteria to boost SCFA production and potentially ameliorate AD progression.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты